85.2%
irinotecan therapycolorectal cancer (CRC)β-GUS inhibitorschemical intervention
…ntially remodelled in diarrhoea and non-diarrhoea patients with irinotecan therapy, and the susceptibility was transmissible to recipient mice via…
1articles mentioning treatments
3treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: irinotecan therapy ×
irinotecan therapy
This treatment is selected. Its supporting articles are shown below.